First Light Asset Management, LLC
An institutional investment manager in Edina, MN. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1600004.
- Reported value$1.65bn
- Positions31
Holdings: 31 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Neogenomics IncNEO | Common Stocks | 64049M209 | 179 | 10.9% | 12,279,523 | Added+2,549,545 | |
| Si-Bone IncSIBN | Common Stocks | 825704109 | 133 | 8.1% | 8,127,985 | Added+2,774,795 | |
| Axogen IncAXGN | Common Stocks | 05463X106 | 127 | 7.7% | 2,748,361 | Reduced−1,254,407 | |
| Apogee Therapeutics Inc | Common Stocks | 03770N101 | 123 | 7.5% | 930,289 | Added+353,605 | |
| Palvella Therapeutics IncPVLA | Common Stocks | 697947109 | 118 | 7.2% | 771,901 | Reduced−208,857 | |
| Twist Bioscience CorporationTWST | Common Stocks | 90184D100 | 74.9 | 4.6% | 727,933 | Reduced−150,915 | |
| Enliven Therapeutics IncELVN | Common Stocks | 29337E102 | 69.1 | 4.2% | 1,360,750 | Added+1,158,883 | |
| Guardant HealthGH | Common Stocks | 40131M109 | 66.3 | 4.0% | 441,586 | Added+161,287 | |
| 908 Devices IncMASS | Common Stocks | 65443P102 | 54.7 | 3.3% | 6,282,804 | Added+210,241 | |
| Amylyx Pharmaceuticals IncAMLX | Common Stocks | 03237H101 | 54.3 | 3.3% | 3,023,256 | Reduced−167,389 | |
| Genedx Holdings CorpWGS | Common Stocks | 81663L200 | 53.8 | 3.3% | 783,923 | Added+540,996 | |
| Simulations Plus Inc | Common Stocks | 829214105 | 51.1 | 3.1% | 2,792,677 | Added+159,854 | |
| Tandem Diabetes Care IncTNDM | Common Stocks | 875372203 | 51.1 | 3.1% | 3,383,553 | Added+2,068,838 | |
| Crinetics Pharmaceuticals Inc | Common Stocks | 22663K107 | 50.9 | 3.1% | 1,360,866 | Added+271,196 | |
| Neuropace IncNPCE | Common Stocks | 641288105 | 45.5 | 2.8% | 2,861,167 | Added+401,201 | |
| Edgewise Therapeutics IncEWTX | Common Stocks | 28036F105 | 44.5 | 2.7% | 1,095,171 | Added+93,325 | |
| Anaptys Bio IncANAB | Common Stocks | 032724106 | 39.3 | 2.4% | 582,004 | Added+16,573 | |
| Trevi Therapeutics IncTRVI | Common Stocks | 89532M101 | 39.1 | 2.4% | 2,097,215 | New+2,097,215 | |
| Septerna IncSEPN | Common Stocks | 81734D104 | 32.3 | 2.0% | 963,260 | Added+230,400 | |
| Trisalus Life Sciences IncTLSI | Common Stocks | 89680M101 | 29.8 | 1.8% | 6,552,491 | Added+1,485,664 | |
| Tectonic Therapeutics IncTECX | Common Stocks | 878972108 | 27.5 | 1.7% | 800,726 | Added+152,983 | |
| Health Catalyst IncHCAT | Common Stocks | 42225T107 | 25.5 | 1.5% | 12,810,861 | Reduced−67,839 | |
| Butterfly Network IncBFLY | Common Stocks | 124155102 | 22.2 | 1.4% | 2,642,404 | Reduced−17,763 | |
| Establishment Labs Holdings | Common Stocks | G31249108 | 21.2 | 1.3% | 246,577 | Reduced−61,161 | |
| Vaxcyte IncPCVX | Common Stocks | 92243G108 | 20.1 | 1.2% | 345,157 | Added+203,373 | |
| Irhythm TechnologiesIRTC | Common Stocks | 450056106 | 19.9 | 1.2% | 167,092 | Reduced−1,024 | |
| Omnicell IncOMCL | Common Stocks | 68213N109 | 18.8 | 1.1% | 452,324 | Reduced−37,522 | |
| Atricure IncATRC | Common Stocks | 04963C209 | 15.9 | 1.0% | 567,838 | Reduced−161,683 | |
| Koru Medical Systems IncKRMD | Common Stocks | 759910102 | 14.2 | 0.9% | 3,387,902 | Reduced−380,478 | |
| Tactile Systems Technology IncTCMD | Common Stocks | 87357P100 | 13.8 | 0.8% | 462,562 | New+462,562 | |
| Rhythm Pharmaceuticals IncRYTM | Common Stocks | 76243J105 | 9.5 | 0.6% | 85,765 | Reduced−1,416 |
Sold out: 6 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals Limited | Common Stocks | 152309100 | 0.0 | 0.0% | 0 | Sold out−1,560,991 | |
| Mimedx Group IncMDXG | Common Stocks | 602496101 | 0.0 | 0.0% | 0 | Sold out−2,842,892 | |
| Organogenesis Holdings IncORGO | Common Stocks | 68621F102 | 0.0 | 0.0% | 0 | Sold out−3,498,533 | |
| Spyglass Pharma IncSGP | Common Stocks | 85220G109 | 0.0 | 0.0% | 0 | Sold out−375,000 | |
| Vera Therapeutics IncVERA | Common Stocks | 92337R101 | 0.0 | 0.0% | 0 | Sold out−313,906 | |
| Wave Life Sciences Ltd | Common Stocks | Y95308105 | 0.0 | 0.0% | 0 | Sold out−1,843,968 |
Source: SEC EDGAR, Form 13F-HR, accession 0001999371-26-018014 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.